PET scanners market seen reaching $2.12B by 2030

The Business Research Company says the global PET scanners market will grow from $1.58 billion in 2025 to $2.12 billion by 2030, driven by cancer imaging demand, hybrid PET-CT and PET-MRI adoption, and expanding uses in neurology and cardiology. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - PET scanners are becoming a bigger part of diagnosis and treatment monitoring for cancer, brain disorders and other chronic diseases. - The market outlook points to continued demand for higher-resolution imaging, hybrid systems and broader clinical use across hospitals and diagnostic centers. - The forecast suggests growing commercial opportunity for scanner makers, detector suppliers and imaging providers as healthcare systems expand access to advanced imaging.

What happened: - The Business Research Company released a report on the positron emission tomography scanners market covering market size, trends and global forecasts for 2026-2035. - The report values the market at $1.58 billion in 2025 and projects $1.66 billion in 2026. - The report forecasts the market will reach $2.12 billion by 2030, implying a 6.3% compound annual growth rate. - North America held the largest regional share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - PET scanners create three-dimensional images using a radioactive substance to detect and analyze organ function. - PET imaging is most often used to locate cancerous tissue and evaluate treatment response. - Market growth is being supported by rising cancer and chronic disease cases that require functional imaging. - Hospital adoption of PET-CT systems for oncology diagnostics is expanding. - Detector advances include gadolinium oxyorthosilicate, bismuth germanium oxide, lutetium fine silicate and lutetium oxyorthosilicate. - Diagnostic imaging facilities are expanding in hospitals and specialty centers. - Clinical evidence supporting PET imaging in treatment planning is increasing. - The report says hybrid PET-MRI and advanced PET-CT platforms are gaining traction. - PET applications are expanding in cardiology, neurology and gastroenterology. - The report also points to wider use of PET-CT and PET-MRI for disease diagnosis and monitoring. - PET scanners are increasingly deployed in hospitals and diagnostic centers worldwide. - The report includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, hotspot infographics and updated graphics and tables. - A free sample report is available here. - The full report is available here.

Between the lines: - The strongest demand is coming from oncology, but the market is widening as PET moves deeper into neurology and cardiology. - Brain disorders are an important growth driver because PET can show metabolic activity that other imaging methods may miss. - The Alzheimer's Association said in March 2024 that about 6.9 million Americans age 65 and older were living with Alzheimer's dementia, and that number is projected to nearly double to 13.8 million by 2060. - That trend reinforces the case for more PET use in neurological care, especially where earlier detection and treatment tracking matter.

What's next: - The report expects broader access to PET scanners in emerging healthcare markets. - Precision imaging for personalized therapy assessment is likely to become a larger buying criterion. - Hybrid and high-resolution imaging systems are expected to remain the main technology focus as hospitals upgrade equipment. - Continued growth in chronic disease diagnosis and treatment monitoring should keep demand rising through 2030. - The report lists contact details for further inquiries and follow-up with The Business Research Company.